Cognetivity Neurosciences Ltd (CSE:CGN) NEW LISTING

Investment Pitch | Season 1

The company is developing a platform technology consisting of a visual stimulus based diagnostic test and artificial intelligence tools to support the early detection and monitoring of cognitive impairment in neurodegenerative diseases.